Predicted to enable RNA binding activity and translation repressor activity. Acts upstream of or within negative regulation of cytoplasmic mRNA processing body assembly. Located in P-body and nucleus. Used to study ovarian disease. Orthologous to human PATL2 (PAT1 homolog 2). [provided by Alliance of Genome Resources, Apr 2022]